Literature DB >> 10521267

Zebrafish (Danio rerio) presenilin promotes aberrant amyloid beta-peptide production and requires a critical aspartate residue for its function in amyloidogenesis.

U Leimer1, K Lun, H Romig, J Walter, J Grünberg, M Brand, C Haass.   

Abstract

Alzheimer's disease (AD) is characterized by the invariable accumulation of senile plaques composed of amyloid beta-peptide (Abeta). Mutations in three genes are known to cause familial Alzheimer's disease (FAD). The mutations occur in the genes encoding the beta-amyloid precursor protein (betaAPP) and presenilin (PS1) and PS2 and cause the increased secretion of the pathologically relevant 42 amino acid Abeta42. We have now cloned the zebrafish (Danio rerio) PS1 homologue (zf-PS1) to study its function in amyloidogenesis and to prove the critical requirement of an unusual aspartate residue within the seventh putative transmembrane domain. In situ hybridization and reverse PCR reveal that zf-PS1 is maternally inherited and ubiquitously expressed during embryogenesis, suggesting an essential housekeeping function. zf-PS1 is proteolytically processed to produce a C-terminal fragment (CTF) of approximately 24 kDa similar to human PS proteins. Surprisingly, wt zf-PS1 promotes aberrant Abeta42 secretion like FAD associated human PS1 mutations. The unexpected pathologic activity of wt zf-PS1 may be due to several amino acid exchanges at positions where FAD-associated mutations have been observed. The amyloidogenic function of zf-PS1 depends on the conserved aspartate residue 374 within the seventh putative transmembrane domain. Mutagenizing this critical aspartate residue abolishes endoproteolysis of zf-PS1 and inhibits Abeta secretion in human cells. Inhibition of Abeta secretion is accompanied by the accumulation of C-terminal fragments of betaAPP, suggesting a defect in gamma-secretase activity. These data provide further evidence that PS proteins are directly involved in the proteolytic cleavage of betaAPP and demonstrate that this function is evolutionarily conserved.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10521267     DOI: 10.1021/bi991453n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  28 in total

1.  In search of gamma-secretase: presenilin at the cutting edge.

Authors:  D J Selkoe; M S Wolfe
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 2.  Metabolism of presenilins.

Authors:  G Thinakaran
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

3.  A gamma-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish.

Authors:  Andrea Geling; Harald Steiner; Michael Willem; Laure Bally-Cuif; Christian Haass
Journal:  EMBO Rep       Date:  2002-07       Impact factor: 8.807

4.  Dietary strontium increases bone mineral density in intact zebrafish (Danio rerio): a potential model system for bone research.

Authors:  Anthony J Siccardi; Steve Padgett-Vasquez; Heath W Garris; Tim R Nagy; Louis R D'Abramo; Stephen A Watts
Journal:  Zebrafish       Date:  2010-09       Impact factor: 1.985

Review 5.  Animal models in the drug discovery pipeline for Alzheimer's disease.

Authors:  Debby Van Dam; Peter Paul De Deyn
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

6.  Structure and Function of the γ-Secretase Complex.

Authors:  Michael S Wolfe
Journal:  Biochemistry       Date:  2019-06-25       Impact factor: 3.162

7.  Analysis of nicastrin gene phylogeny and expression in zebrafish.

Authors:  Anne Lim; Seyyed Hani Moussavi Nik; Esmaeil Ebrahimie; Michael Lardelli
Journal:  Dev Genes Evol       Date:  2015-05-05       Impact factor: 0.900

8.  Can zebrafish be used as animal model to study Alzheimer's disease?

Authors:  Soraya Santana; Eduardo P Rico; Javier S Burgos
Journal:  Am J Neurodegener Dis       Date:  2012-05-15

9.  Using zebrafish to assess the impact of drugs on neural development and function.

Authors:  Su Guo
Journal:  Expert Opin Drug Discov       Date:  2009-07-01       Impact factor: 6.098

10.  Quantification of gamma-secretase modulation differentiates inhibitor compound selectivity between two substrates Notch and amyloid precursor protein.

Authors:  Ting Yang; Dilyara Arslanova; Yongli Gu; Corinne Augelli-Szafran; Weiming Xia
Journal:  Mol Brain       Date:  2008-11-04       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.